Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?

被引:2
作者
Yeh, Hsin-Chih [1 ,2 ,3 ,4 ]
Chien, Tsu-Ming [3 ]
Wu, Wen-Jeng [1 ,2 ,3 ,4 ,5 ]
Li, Ching-Chia [1 ,2 ,3 ,4 ]
Li, Wei-Ming [2 ,3 ,4 ,6 ,7 ]
Ke, Hung-Lung [2 ,3 ,4 ]
Chou, Yii-Her [2 ,3 ]
Wang, Chii-Jye [2 ,3 ]
Huang, Shu-Pin [2 ,3 ]
Li, Chien-Feng [8 ,9 ,10 ]
Liang, Peir-In [11 ]
Huang, Chun-Nung [2 ,3 ]
机构
[1] Kaohsiung Municipal Tatung Hosp, Dept Urol, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Urol, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan
[6] Minist Hlth, Dept Urol, Pingtung, Taiwan
[7] Welf Pingtung Hosp, Pingtung, Taiwan
[8] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan
[9] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan
[10] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan
[11] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan
关键词
Anemia; Metastasis; Prognosis; Upper tract urothelial carcinoma; UPPER URINARY-TRACT; ONCOLOGIC OUTCOMES; CELL CARCINOMA; CANCER; RECURRENCE; MANAGEMENT; PROGNOSIS; SURVIVAL; IMPACT; CKD;
D O I
10.1016/j.urolonc.2016.03.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We aimed to identify the effect of preoperative anemia on oncologic outcomes in patients with upper tract urothelial carcinoma (UTUC) who had different levels of renal function. Methods: Between 2000 and 2013, we enrolled 370 patients who underwent radical nephroureterectomy for nonmetastatic UTUC. Preoperative anemia was defined as hemoglobin <130 g/l in men and <120 g/l in women based on the World Health Organization classification. Kaplan-Meier method was applied to estimate the effect anemia on survival, and hazard ratios (HR) of anemia and other clinicopathological parameters were evaluated by Cox regression model. The analyses were also performed in patients with different chronic kidney disease (CKD) stages. Results: In all, 242 (65.4%) patients were anemic before surgery. Those with preoperative anemia had worse CKD stage (P < 0.001) and higher pathological tumor stage (P = 0.023). In univariate analysis, metastasis-free and cancer-specific survival rates were not significantly associated with preoperative anemia (HR = 1.51, 95% CI: 0.93-2.44, P = 0.093 and HR = 1.59, 95% CI: 0.93-2.72, PP = 0.094, respectively). However, in patients without stage 5 CKD, those with preoperative anemia had apparently inferior metastasis-free and cancer-specific survival than those without (HR = 1.88, 95% CI: 1.14-3.01, P = 0.014 and HR = 2.03, 95% CI: 1.16-3.56, P = 0.010, respectively). A multivariate Cox proportional hazards model indicated that preoperative anemia was an independent predictor for both metastasis-free (HR = 2.17, 95% CI: 1.21-3.90, P = 0.010) and cancer-specific survival (HR = 2.21, 95% CI: 1.15-4.21, P = 0.017). Conclusions: Among patients without stage 5 CKD, preoperative anemia was a significant prognostic factor to predict metastatic progression and cancer-specific death in UTUC following radical nephroureterectomy. It was important to be aware of patients' renal function while evaluating the effect of anemia on outcome of UTUC. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:337.e1 / 337.e9
页数:9
相关论文
共 31 条
[1]  
Amato A., 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005033.PUB2
[2]   Mechanisms of Anemia in CKD [J].
Babitt, Jodie L. ;
Lin, Herbert Y. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10) :1631-1634
[3]  
Brugnara C, 2011, BRENNER RECTORS KIDN, P2081
[4]  
Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO
[5]  
2-P
[6]   CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma [J].
Chung, Shiu-Dong ;
Huang, Kuo-How ;
Lai, Ming-Kuen ;
Huang, Chao-Yuan ;
Chen, Chung-Hsin ;
Pu, Yeong-Shiau ;
Yu, Hong-Jeng ;
Chueh, Shih-Chieh .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (05) :743-753
[7]   Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF) [J].
Dunst, J ;
Becker, A ;
Lautenschläger, C ;
Markau, S ;
Becker, H ;
Fischer, K ;
Haensgen, G .
STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (08) :436-441
[8]   Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy [J].
Gierth, M. ;
Mayr, R. ;
Aziz, A. ;
Krieger, S. ;
Wullich, B. ;
Pycha, A. ;
Lodde, M. ;
Salvadori, U. ;
Bruendl, J. ;
Fritsche, H. M. ;
Hofstaedter, F. ;
Pawlik, M. T. ;
Otto, W. ;
May, M. ;
Burger, M. ;
Denzinger, S. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (10) :1819-1826
[9]   Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours [J].
Graeber, TG ;
Osmanian, C ;
Jacks, T ;
Housman, DE ;
Koch, CJ ;
Lowe, SW ;
Giaccia, AJ .
NATURE, 1996, 379 (6560) :88-91
[10]   Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer [J].
Hazzan, Azzour D. ;
Shah, Hitesh H. ;
Hong, Susana ;
Sakhiya, Vipulbhai ;
Wanchoo, Rimda ;
Fishbane, Steven .
KIDNEY INTERNATIONAL, 2014, 86 (01) :34-39